Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.12 - $7.52 $9.61 Million - $23.2 Million
-3,080,633 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$6.26 - $14.42 $443,089 - $1.02 Million
-70,781 Reduced 2.25%
3,080,633 $22.3 Million
Q2 2021

Aug 16, 2021

BUY
$20.08 - $29.02 $23.4 Million - $33.8 Million
1,164,874 Added 58.64%
3,151,414 $75.5 Million
Q1 2021

May 14, 2021

BUY
$27.0 - $32.48 $53.6 Million - $64.5 Million
1,986,540 New
1,986,540 $58.1 Million

Others Institutions Holding KRON

About Kronos Bio, Inc.


  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $55.1M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.